Kymera Therapeutics, Inc. Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kymera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kymera Therapeutics, Inc. for August 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 180,686 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,000,955 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,336,390 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 67,791 | 1,355,820 | 181,081 | 113.3 K to 181.1 K (+59.84 %) |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 113,290 | 0 | 113,290 | 0 to 113.3 K |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 389,709 | 7,794,180 | 1,017,307 | 627.6 K to 1 M (+62.10 %) |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 627,598 | 0 | 627,598 | 0 to 627.6 K |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 521,193 | 10,423,860 | 1,359,109 | 837.9 K to 1.4 M (+62.20 %) |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 837,916 | 0 | 837,916 | 0 to 837.9 K |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 246,305 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 467,932 | 0 | 467,932 | 0 to 467.9 K |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,600,740 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,630,660 | 0 | 1,630,660 | 0 to 1.6 M |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Hall Steven Edward | Director | Option Exercise | C | 0.00 | 985,220 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Hall Steven Edward | Director | Option Exercise | C | 0.00 | 2,511,198 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Hall Steven Edward | Director | Buy | C | 0.00 | 2,192,249 | 0 | 2,192,249 | 0 to 2.2 M |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,774,624 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,477,832 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 1,112,686 | 0 | 1,112,686 | 0 to 1.1 M |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 7,196,584 | 0 | 7,948,982 | 752.4 K to 7.9 M (+956.49 %) |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 1,774,624 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 1,477,832 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Buy | C | 0.00 | 1,112,686 | 0 | 1,112,686 | 0 to 1.1 M |
| Aug 25 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Buy | C | 0.00 | 7,196,584 | 0 | 7,948,982 | 752.4 K to 7.9 M (+956.49 %) |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | A | 20.00 | 48,942 | 978,840 | 48,942 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Nicholson Donald William | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Chesworth Richard | Chief Scientific Of ... | Option Exercise | A | 20.00 | 351,119 | 7,022,380 | 351,119 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Albers Jeffrey W. | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | President and CEO | Option Exercise | A | 20.00 | 125,399 | 2,507,980 | 125,399 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Hrustanovic Gorjan | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Hall Steven Edward | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Hedin Andrew | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Horobin Joanna | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | A | 20.00 | 32,904 | 658,080 | 32,904 |